Back
Relmada Therapeutics Stock Price Chart
Sponsored
RLMD
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
40
RLMD
Relmada Therapeutics
Last Price:
3.74
Seasonality Move:
-13.22%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
Relmada Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.75 | Sell |
20-day SMA: | 4.24 | Sell |
50-day SMA: | 5 | Sell |
200-day SMA: | 3.7 | Sell |
8-day EMA: | 3.8 | Sell |
20-day EMA: | 4.16 | Sell |
50-day EMA: | 4.51 | Sell |
200-day EMA: | 4.46 | Sell |
Relmada Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 35.52 | Sell |
Chaikin Money Flow: | -21333 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.89 - 4.79) | Sell |
Bollinger Bands (100): | (3.28 - 5.52) | Sell |
Relmada Therapeutics Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Relmada Therapeutics Stock
Is Relmada Therapeutics Stock a Buy?
- Relmada Therapeutics share price is 3.69 while RLMD 8-day simple moving average is 3.75, which is a Sell signal.
- The stock price of RLMD is 3.69 while Relmada Therapeutics 20-day SMA is 4.24, which makes it a Sell.
- Relmada Therapeutics 50-day simple moving average is 5.00 while RLMD share price is 3.69, making it a Sell technically.
- RLMD stock price is 3.69 and Relmada Therapeutics 200-day simple moving average is 3.70, creating a Sell signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
40
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy or a Sell?
-
Relmada Therapeutics stock is rated a Sell
The current Relmada Therapeutics [RLMD] share price is $3.69. The Score for RLMD is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics Stock Info
Market Cap:
111.34M
Price in USD:
3.69
Share Volume:
64K
Relmada Therapeutics 52-Week Range
52-Week High:
7.22
52-Week Low:
2.36
Sell
40
Relmada Therapeutics (RLMD)
is a Sell
Relmada Therapeutics Share Price Forecast
-
What is the Relmada Therapeutics stock price today?
The Relmada Therapeutics stock price is 3.69 USD today. -
Will RLMD stock go up or go down?
Relmada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relmada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics is overvalued.
Is Relmada Therapeutics Stock a Buy?
- Relmada Therapeutics share price is 3.69 while RLMD 8-day exponential moving average is 3.80, which is a Sell signal.
- The stock price of RLMD is 3.69 while Relmada Therapeutics 20-day EMA is 4.16, which makes it a Sell.
- Relmada Therapeutics 50-day exponential moving average is 4.51 while RLMD share price is 3.69, making it a Sell technically.
- RLMD stock price is 3.69 and Relmada Therapeutics 200-day simple moving average is 4.46, creating a Sell signal.
Fundamental Analysis of Relmada Therapeutics
Is Relmada Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.39 per share.
Technical Analysis of Relmada Therapeutics
Should I short Relmada Therapeutics stock?
- RLMD Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Relmada Therapeutics is a Sell
- Relmada Therapeutics Relative Strength Index (RSI) is 35.52, which suggest Relmada Therapeutics is oversold
- The Bollinger Bands (25) for Relmada Therapeutics is (3.89 - 4.79), which suggest Relmada Therapeutics is a Sell
- The Bollinger Bands (100) for Relmada Therapeutics is (3.28 - 5.52), which suggest Relmada Therapeutics is a Sell
* Relmada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.